NEW YORK--(BUSINESS WIRE)--Pfizer Inc announced that it has updated the U.S. product labeling for CHANTIX® (varenicline), a prescription aid to smoking cessation treatment, to communicate important ...
For the third time this summer, Pfizer issued a recall of popular anti-smoking medication Chantix that might have too much of the carcinogen N-nitroso-varenicline. That’s too much for Pfizer, not the ...
The FDA has released the following: Pfizer is voluntarily recalling all lots of Chantix 0.5 mg and 1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results